Clinical Trial Update: Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether extended dosing of abatacept is as effective as short-term dosing for preventing graft-versus-host disease, and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Graft Vs Host Disease | Phase 2 | Status: RECRUITING